Sign In
About ASHM | Careers | Your Cart Shoppint Cart
Skip Navigation LinksASHM Internet Home > ASHM Courses > Hepatitis C in Drug and Alcohol Settings Education Program


Public Training

When & Where

Rydges Adelaide

Adelaide SA

May 6, 2017

8:30 AM to 5:00 PM



Hepatitis C in Drug and Alcohol Settings Education Program

Hepatitis C |
1 Day Course |
GPs; Nurses |
SA |
This session has been developed in collaboration with drug & alcohol clinicians, hepatology specialists, GPs, nurses and representatives from drug user community organisations.

For more information, please click here to download the course flyer



This Education Program is designed to give participants the confidence, knowledge and clinical decision-making skills to be able to prescribe new Direct Acting Antiviral (DAA) Therapy for the treatment of HCV infection, either independently or in collaboration with a specialist as appropriate.

This course is being offered in collaboration with The Kirby Institute, UNSW Australia, South Australian Network of Drug and Alcohol Services and Hepatitis South Australia.

The course will be delivered in three parts:

• Part 1 consists of a 2 hour eLearning component introducing the learner to the assessment, management and treatment of hepatitis C in drug and alcohol settings.

• Part 2 consists of an interactive face-to-face workshop building on the knowledge and skills gained in Part 1 through practical case discussions and simulation-based models.

• Part 3 consists of a tailored capacity strengthening toolkit including: a checklist for the assessment and treatment of HCV in drug and alcohol settings; local referral pathways; Fibroscan® access forms; assessment pro forma; and quick reference guides.

Learning Outcomes:

• Describe the risk factors for HCV infection enabling effective practice screening processes and recall systems

• Demonstrate competence interpreting clinical and other relevant information to provide effective care of people living with HCV infection

• Demonstrate competence in liver disease assessment

• Demonstrate understanding of DAA therapy for the treatment of HCV and competence in selecting and prescribing appropriate therapy

• Monitor patients on treatment and post-treatment appropriately


Addiction Specialists, Physicians, General Practitioners, Nurse Practitioners and other clinical staff interested in treating hepatitis C


Morning Tea, Lunch and Afternoon Tea to be provided.

This workshop has been supported by Gilead Sciences Ltd.

For further Information Contact:

Natalie Huska (Project support Officer):

T 02 8204 0784


Conditions of registration:

Registration Cancellations:

Registration cancellations and amendments must be notified in writing to ASHM. Cancellations received before 2 May 2017 will not incur a cancellation fee. Cancellations received in writing after 2 May 2017 will incur a $70 per day cancellation fee. This fee may be waived in exceptional circumstances at the discretion of ASHM.


As an alternative to cancellation, your registration may be transferred to another person without incurring any penalty. ASHM must be advised of the transfer in writing. Please email the name, position, phone and email address of the new delegate to

Related Courses



CROI Update Update1/03/2017 11:59:00 AMVICAn update for health practitioners working in the field of HIV, brought to you from the CROI conference in Seattle.Melbourne
deLiver a healthier outcome: Update in hepatitis B and C for Primary Care Providers offering Refugee Health Services a healthier outcome: Update in hepatitis B and C for Primary Care Providers offering Refugee Health Services2/03/2017 11:59:00 AMQLDThis course is designed to provide GPs and Nurses with the tools to diagnose, manage and holistically support Refugee patients with viral hepatitis.Brisbane
Hepatitis B s100 Prescriber B s100 Prescriber5/03/2017 11:59:00 AMVICThis training will enable GPs to effectively diagnose, manage and treat chronic hepatitis B in the primary care setting.Melbourne
Hepatitis B & C Management in Primary Care B & C Management in Primary Care8/03/2017 11:59:00 AMVICIntroductory level for Viral Hepatitis management in primary care.Melbourne
Update in Hepatitis B for primary care practitioners in Hepatitis B for primary care practitioners9/03/2017 11:59:00 AMTasmaniaUpdate in Hepatitis B - North Hobart, TASNorth Hobart

Please enter a valid E-mail.
This must match your colleagues E-mail.
Please enter your name.
Please enter a valid email.
This must match your email.